Clinical Trials Logo

Bone Loss clinical trials

View clinical trials related to Bone Loss.

Filter by:

NCT ID: NCT05764733 Recruiting - Bone Loss Clinical Trials

Bone, Exercise, Alendronate, and Caloric Restriction

BEACON
Start date: June 8, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this research is to identify strategies that minimize bone loss that occurs when older adults lose weight. Participation in this research will involve up to nine assessment visits and last up to two years.

NCT ID: NCT05701254 Recruiting - Type 1 Diabetes Clinical Trials

Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk

Start date: June 18, 2019
Phase:
Study type: Observational

Patients with Type 1 Diabetes Mellitus (T1DM) have a higher risk of low-trauma (osteoporotic) fracture that is 7-12 times higher than non-diabetics. The bone density of people with Type 1 Diabetes is higher at the time of fracture than in non-diabetics. This suggests the presence of underlying bone tissue mechanical defects. The potential benefits to participants would be knowledge gained about their bone density and the results of laboratory tests. On a wider scale, there may be general benefits to society because the knowledge gained from this study may help better understand the effects of diabetes on bone health

NCT ID: NCT05658289 Recruiting - Bone Loss Clinical Trials

Latarjet vs Anatomic Glenoid Reconstruction

Start date: April 24, 2023
Phase: N/A
Study type: Interventional

Anterior shoulder dislocations occur when the humeral head translates anterior to the glenoid cause pain, stiffness, and glenoid bone loss. If left untreated, the risk of recurrence can be up to or greater than 90%. The only surgically modifiable factor to reduce the risk of recurrence is the glenoid bone loss (GBL), where surgeons have the ability to recreate the shape of the glenoid and reduce the risk of recurrent shoulder dislocations. Established boney procedures for shoulder instability include the Latarjet and free bone block procedures, such as the Anatomic Glenoid Reconstruction (AGR). The Latarjet is well known for its lower rate of recurrent instability, but raises concerns due to under-appreciated complications rates. The AGR is a newer surgical approach that has garnered attention for its low rate of recurrent instability and complication profile. Both treatments can reduce pain, increase function following surgery and reduce the risk of recurrent instability. However, these two established approaches have yet to be directly compared and studied on a larger scale. The purpose of this randomized control trial is to compare clinical and radiographic outcomes pre- and post-operatively between the Latarjet to the AGR.

NCT ID: NCT05615402 Recruiting - Cerebral Palsy Clinical Trials

Intervention on Bone Health in Wheelchair Users

BoneWheel
Start date: December 1, 2022
Phase: N/A
Study type: Interventional

The low mechanical loading of bones among wheelchair users leads to an increased risk of bone fractures and associated complications due to low bone mineral density (BMD). Adding mechanical loading through physical activity in combination with optimizing nutrition may counteract these negative consequences in wheelchair users and thereby provide positive impact for bone health, as well as for physical and mental health. In this project, a multidisciplinary team will tailor a bone-specific exercise and nutrition program to increase BMD in sport active and non-active wheelchair users with initial low BMD.

NCT ID: NCT05548517 Recruiting - Weight Loss Clinical Trials

TRE: Microbiome, Metabolic Health and Bone

TREMBO
Start date: October 15, 2022
Phase: N/A
Study type: Interventional

In the Time-Restricted Eating: Microbiome and Bone (TREMBO) study, the primary goal is to determine the effect of time-restricted eating with caloric restriction compared to caloric restriction alone on body weight, the gut microbiota, and bone health in older women who are overweight or obese.

NCT ID: NCT05510011 Recruiting - Bone Loss Clinical Trials

Allograft and Tantalum Cone Reconstruction in TKA Revision

Start date: January 1, 2022
Phase:
Study type: Observational

A new surgical technique of reconstruction for bone loss in TKA revision using tantalum cone and allograft. Study of radiological and clinical outcomes.

NCT ID: NCT05467644 Recruiting - Bone Loss Clinical Trials

Treatment of Fracture Related Infection in Latin America.

Start date: January 1, 2021
Phase:
Study type: Observational

Postoperative bone infection is a severe complication in the treatment of fractures and is more frequent than in elective joint replacement surgeries. Surgical treatment is based on meticulous debridement of bone and soft tissue, dead space management, soft tissue reconstruction when necessary, and restoration of bony stability in the non-union fracture. In addition, local antibiotic therapy is recommended in certain circumstances. This study aims to evaluate the results of surgical treatment of fracture-related infection in Latin America.

NCT ID: NCT05303636 Recruiting - Bone Loss Clinical Trials

LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

Start date: March 28, 2022
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to evaluate the impact of LF111 and drospirenone (DRSP) 3.5 mg chewable tablets on bone mineral density (BMD) at the lumbar spine after 12 months (13 medication cycles) of investigation in comparison to non-hormonal contraceptive methods. Secondary objectives include further evaluating the impact of LF111 and DRSP 3.5 mg chewable tablets on BMD and bone turnover after 12 months (13 medication cycles) in comparison to non-hormonal contraceptive methods and assessing the general safety and tolerability of LF111 and DRSP 3.5 mg chewable tablets in comparison to non-hormonal contraceptive methods. Exploratory objectives include evaluating the impact of LF111 and DRSP 3.5 mg chewable tablets on body fat and lean mass after 12 months (13 medication cycles) of investigation.

NCT ID: NCT05240417 Recruiting - Bone Loss Clinical Trials

"Pontic-shield" Technique in Alveolar Ridge Preservation

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Alveolar bone resorption after dental extraction frequently leads to situations in which long-term function and esthetic success of rehabilitations with dental implants is a challenge. "Pontic-shield" has been described as an alternative technique to maintain alveolar ridge after tooth extraction. The aim of this study is to analyze the effectiveness of "Pontic-shield" technique in alveolar ridge preservation comparing to fresh socket and ridge preservation using deproteinized bovine bone and a porcine collagen membrane.

NCT ID: NCT05237570 Recruiting - Bone Loss Clinical Trials

Minimally Invasive Sinus Lift Through the Interradicular Septum

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

This study aims to describe a new approach for the reconstruction of the alveolar process in the sinus area. This minimally invasive approach will access the maxillary sinus through the alveolar process, elevating the sinus membrane in the area immediately above it. The regeneration may be achieved in the specific area required for dental implant placement, reducing the morbidity of the procedure.